|4Jan 5, 9:02 AM ET

Coelho Mary Theresa 4

4 · First Wave BioPharma, Inc. · Filed Jan 5, 2023

Insider Transaction Report

Form 4
Period: 2023-01-03
Transactions
  • Award

    Common Stock

    2023-01-03+84,74584,745 total
Footnotes (2)
  • [F1]On January 3, 2023, the Reporting Person was granted 84,745 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest quarterly for one year with 25% vesting quarterly beginning March 31, 2023.
  • [F2]Includes unvested RSUs.

Documents

1 file
  • 4
    tm231522-7_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT